2021
Annual Revenue Crossed INR 2 Billion Mark
Another milestone achieved. And with our therapy-centric business model, deep understanding of chronic segments, an eye for innovation and above all a very young, dynamic & motivated team, we are confident that Septalyst is poised for tremendous growth.